A detailed history of Hfr Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hfr Wealth Management, LLC holds 1,533 shares of ABBV stock, worth $308,439. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,533
Previous 1,533 -0.0%
Holding current value
$308,439
Previous $279,000 6.09%
% of portfolio
0.07%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $2,024 - $2,331
-14 Reduced 0.9%
1,533 $244,000
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $5,368 - $6,157
-40 Reduced 2.52%
1,547 $208,000
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $6,330 - $8,048
-46 Reduced 2.82%
1,587 $243,000
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $4,751 - $5,895
-36 Reduced 2.16%
1,633 $265,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $179,300 - $226,867
1,669 New
1,669 $226,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hfr Wealth Management, LLC Portfolio

Follow Hfr Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hfr Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hfr Wealth Management, LLC with notifications on news.